264 related articles for article (PubMed ID: 1980237)
1. Elevated c-myc messenger RNA in multiple myeloma cell lines.
Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
[TBL] [Abstract][Full Text] [Related]
2. Aberrant translational control of the c-myc gene in multiple myeloma.
Paulin FE; West MJ; Sullivan NF; Whitney RL; Lyne L; Willis AE
Oncogene; 1996 Aug; 13(3):505-13. PubMed ID: 8760292
[TBL] [Abstract][Full Text] [Related]
3. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
Erisman MD; Scott JK; Watt RA; Astrin SM
Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
[TBL] [Abstract][Full Text] [Related]
4. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
5. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
6. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
8. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
9. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
10. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
11. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
12. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
[TBL] [Abstract][Full Text] [Related]
14. Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro.
Suchy BK; Sarafoff M; Kerler R; Rabes HM
Cancer Res; 1989 Dec; 49(23):6781-7. PubMed ID: 2684400
[TBL] [Abstract][Full Text] [Related]
15. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
16. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
Untawale S; Blick M
Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
[TBL] [Abstract][Full Text] [Related]
17. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor.
Yander G; Halsey H; Kenna M; Augenlicht LH
Cancer Res; 1985 Sep; 45(9):4433-8. PubMed ID: 4028026
[TBL] [Abstract][Full Text] [Related]
18. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
19. Patterns of proto-oncogene expression in human glioma cell lines.
LaRocca RV; Rosenblum M; Westermark B; Israel MA
J Neurosci Res; 1989 Sep; 24(1):97-106. PubMed ID: 2810398
[TBL] [Abstract][Full Text] [Related]
20. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
